Extra CHF1bn needed to decommission Swiss nuclear plants
Keystone
Decommissioning Switzerland’s five nuclear power stations and dealing with radioactive waste will cost CHF1.1 billion ($1.15 billion) more than previously estimated. The total bill is now expected to reach CHF24.6 billion, the environment ministry said on Thursday.
This content was published on
1 minute
swissinfo.ch/mga
In 2011, Switzerland decided to phase out nuclear power, which supplies on average 35% of the country’s electricity production, following the Fukushima disaster in Japan.
While no exact timetable has been set for all five plants to be taken out of service, the government has worked out the cost of the operation. Some CHF3.8 billion has been earmarked to break down the facilities and a further CHF20.8 billion is needed to dispose of radioactive waste safely.
Previous estimates had put total costs at CHF23.5 billion, but this had included potential savings from cantons joining forces to dispose of waste and a resultant expectation that compensation costs would be reduced. These savings have been stripped out of the revised budget as no concrete plans have been laid down as to how to achieve this.
The bill will be met from two separate funds – one for decommissioning facilities and the other to cover waste disposal – consisting of contributions from nuclear plant operators.
In May 2017, Swiss voters endorsed a new energy law that aims to promote renewable energy by banning new nuclear power plants and reducing energy consumption.
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Basel greenlights funding for Eurovision Village 2025
This content was published on
MCH Group Ltd. is set to receive CHF1 million ($1.1 million) for the Eurovision Village at the Eurovision Song Contest 2025 in Basel.
Geneva researchers discover potential for targeted cancer drug delivery
This content was published on
Researchers in Geneva have discovered how some bacteria inject dangerous enzymes into cells, potentially enabling targeted drug delivery to cancer cells.
Macron denies involvement in Nestlé Waters scandal
This content was published on
French President Emmanuel Macron denied any “agreement” or “collusion” with the Swiss company Nestlé over the bottled water scandal on Tuesday.
UBS has cut 10,000 jobs since Credit Suisse takeover in 2023
This content was published on
UBS Group has cut more than 10,000 roles since it bought Credit Suisse, marking a milestone in the lender’s efforts to integrate its former rival.
Swiss multinational SGS to move HQ from Geneva to Zug
This content was published on
The Swiss multinational SGS, the world’s leading testing, inspection and certification company, plans to move its headquarters from Geneva to canton Zug in central Switzerland.
Swiss army takes part in international tank competition
This content was published on
Around 20 Swiss army personnel and two Leopard 2 tanks are taking part in an international tank competition in Grafenwöhr, Germany, this week.
Omega-3 supplements seem to slow ageing process, Swiss study finds
This content was published on
Taking a daily omega-3 supplement appears to slow down the rate of biological ageing by up to four months, according to a study by researchers at the University of Zurich.
This content was published on
The agency running the canton Bern plant told Swiss public television that it wants to have the treatment facility up and running by 2025, and treating the radioactive waste for the following 30 years. But a spokesperson would not reveal how much it would cost, how big it would be or where it will be…
This content was published on
Banning construction of nuclear power plants and limiting to 45 years the use of existing ones: that's an issue before Swiss voters in November.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.